Göm menyn

Publications for Anna Asplund Persson

Co-author map based on Web of Sciences articles 2007-

Journal Articles

Anna Asplund Persson, Stefan Zalavary, Eva Lindström, Per A Whiss, Torbjörn Bengtsson and Magnus Grenegård
  Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets
  European Journal of Pharmacology, 2005, 517(3), 149-157.
 Web of Science® Times Cited: 2

Anna Asplund Persson, Peter Gunnarsson, Eva Lindström and Magnus Grenegård
  Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries
  European Journal of Pharmacology, 2005, 521(1-3), 124-132.
 Web of Science® Times Cited: 2

Anna K Asplund Persson, Louise Palmér, Peter Gunnarsson and Magnus Grenegård
  Characterisation of GEA 3175 on human platelets: comparison with S-nitroso-N-acetyl-D,L-penicillamine
  European Journal of Pharmacology, 2004, 496(1-3), 1-9.
 Web of Science® Times Cited: 9

R. Støen, K. Lossius, Anna Asplund-Persson and J. Karlsson
  Relative significance of the nitric oxide (NO)/cGMP pathway and K+ channel activation in endothelium-dependent vasodilation in the femoral artery of developing piglets
  Acta Physiologica Scandinavica, 2001, 171(1), 29-35.
 Web of Science® Times Cited: 9

Conference Articles

Magnus Grenegård, Eva Lindström, Anna Asplund-Persson and Peter Gunnarsson
  Mechanisms underlying platelet desensitisation towards nitric oxide
  XIV International Symposium on Atherosclerosis Rom, 2006.

Ph.D. Theses

Anna Asplund Persson
  Pharmacological evaluation of the NO/cGMP signalling system


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30